Reactive Oxygen Species-Responsive Diselenide-Bridged Silica Nanoparticles Reprogram Ferroptosis for Inflammatory Bowel Disease Therapy
ACS Nano · 21.11.2026
DOI: 10.1021/acsnano.6c14154 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 21.11.2026. Verfasst von Tongfei Shi und 11 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Natural Science Foundation of Beijing Municipality.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) is driven by persistent epithelial injury and unresolved immune activation, yet effective therapies remain limited by an incomplete understanding of its spatiotemporal pathological mechanisms. Here, single-cell transcriptomic profiling reveals a previously unrecognized ferroptotic landscape in intestinal mucosa, characterized by rapid depletion of ferroptosis suppressor protein 1 (FSP1) in epithelial cells followed by delayed exhaustion of glutathione peroxidase 4 (GPX4) in macrophages. Guided by this mechanistic insight, we engineered a reactive oxygen species (ROS)-responsive nanoselenium to deliver ferrostatin-1 (Fer-1) by a diselenide-bridged silica carrier to achieve spatiotemporal ferroptosis regulation. In response to pathological ROS, our nanoplatform rapidly releases Fer-1 to alleviate epithelial injury and maintain barrier integrity, followed by sustained selenium release to reactivate macrophage GPX4, thereby resolving the inflammatory responses. This sequential ferroptosis intervention effectively disrupts the pathogenic interplay between epithelial damage and inflammatory amplification, leading to a robust recovery of intestinal architecture and immune homeostasis with excellent biocompatibility. Collectively, our work identifies ferroptosis as a mechanistic link between epithelial dysfunction and immune dysregulation and establishes a mechanism-guided nanomedicine paradigm for spatiotemporal regulation of inflammatory bowel disease.
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Natural Science Foundation of Beijing Municipality
- Beijing Nova Program
- Medical Science and Technology Foundation of Guangdong Province
- National Key Research and Development Program of China
- Fundamental Research Funds for the Central Universities
- Jilin Provincial Scientific and Technological Development Program
Zitieren
APA
Shi, T., Zhou, Y., Xu, J., Zhou, Y., Chen, X., Zhao, X., Xie, X., Wu, Z., Ning, Q., Su, H., Qian, J., & Zhang, Y. (2026). Reactive Oxygen Species-Responsive Diselenide-Bridged Silica Nanoparticles Reprogram Ferroptosis for Inflammatory Bowel Disease Therapy. ACS Nano. https://doi.org/10.1021/acsnano.6c14154
Vancouver
Shi T, Zhou Y, Xu J, Zhou Y, Chen X, Zhao X, et al. Reactive Oxygen Species-Responsive Diselenide-Bridged Silica Nanoparticles Reprogram Ferroptosis for Inflammatory Bowel Disease Therapy. ACS Nano. 2026. doi:10.1021/acsnano.6c14154
BibTeX
@article{Shi2026,
author = {Shi, Tongfei and Zhou, Ying and Xu, Jiaqi and Zhou, Yifan and Chen, Xuenian and Zhao, Xin and Xie, Xiaochun and Wu, Ziping and Ning, Quanxin and Su, Hang and Qian, Jieying and Zhang, Yunjiao},
title = {Reactive Oxygen Species-Responsive Diselenide-Bridged Silica Nanoparticles Reprogram Ferroptosis for Inflammatory Bowel Disease Therapy},
journal = {ACS Nano},
year = {2026},
doi = {10.1021/acsnano.6c14154}
}
EUVIMED